Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:31 PM UTC
| NCT Number | NCT06547489 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 164 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Syndeio Biosciences, Inc |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06547489 is currently recruiting participants. This phase2 study for major depressive disorder is actively seeking new participants at 34 locations across the United States. The study is sponsored by Syndeio Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06547489 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06547489 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.